Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System
Open Access
- 15 June 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (12) , 4400-4405
- https://doi.org/10.1158/1078-0432.ccr-04-2378
Abstract
Purpose: Enhanced prognostication power is becoming more desirable in clinical oncology. In this study, we explored the prognostic potential of multigene hypermethylation profiling in non–small-cell lung cancer.Keywords
This publication has 23 references indexed in Scilit:
- The relationship between aberrant methylation and survival in non-small-cell lung cancersBritish Journal of Cancer, 2004
- Hypermethylation ofFHITas a prognostic marker in nonsmall cell lung carcinomaCancer, 2004
- Ataxia-Telangiectasia-Mutated ( ATM ) Gene in Head and Neck Squamous Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Cyclin E and Survival in Patients with Breast CancerNew England Journal of Medicine, 2002
- Aberrant DNA Methylation in Lung Cancer: Biological and Clinical ImplicationsThe Oncologist, 2002
- Focus on lung cancerPublished by Elsevier ,2002
- Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survivalOncogene, 2001
- Simulation Modeling of the Tissue Disposition of Formaldehyde to Predict Nasal DNA-Protein Cross-Links in Fischer 344 Rats, Rhesus Monkeys, and HumansEnvironmental Health Perspectives, 2000
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996